Abstract
The growing threat of antibiotic-resistant bacteria has necessitated the exploration of novel therapeutic strategies, including the incorporation of nanotechnology in the development of new antibiotics. Nanotechnology offers innovative solutions to enhance the efficacy of existing antibiotics and create entirely new classes of antimicrobial agents. This paper examines the potential of nanotechnology in the development of antibiotics, focusing on nanoparticles, nanocarriers, and nanoantibiotics, and their ability to overcome bacterial resistance mechanisms. The use of nanotechnology in drug delivery, targeted treatment, and synergistic effects with conventional antibiotics is discussed. We also address the challenges associated with nanotoxicity, regulatory concerns, and the future perspectives of nanotechnology in combating bacterial infections.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. John Doe (Author)